{"id":"NCT04136184","sponsor":"Ionis Pharmaceuticals, Inc.","briefTitle":"NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy","officialTitle":"A Phase 3 Global, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-12-11","primaryCompletion":"2023-04-11","completion":"2023-07-12","firstPosted":"2019-10-23","resultsPosted":"2024-12-10","lastUpdate":"2024-12-13"},"enrollment":168,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hereditary Transthyretin-Mediated Amyloid Polyneuropathy"],"interventions":[{"type":"DRUG","name":"Inotersen","otherNames":["TEGSEDI","ISIS 420915"]},{"type":"DRUG","name":"Eplontersen","otherNames":["ION-682884","AKCEA-TTR-LRx","IONIS-TTR-LRx"]}],"arms":[{"label":"Inotersen","type":"ACTIVE_COMPARATOR"},{"label":"Eplontersen","type":"EXPERIMENTAL"}],"summary":"The main objective of this study was to evaluate the efficacy of eplontersen as compared with the historical control of the placebo cohort in the NEURO-TTR trial (NCT01737398/2012-001831-30), in subjects with hereditary transthyretin-mediated amyloidosis polyneuropathy (hATTR-PN). For more information, please visit http://www.neuro-ttransform.com/.","primaryOutcome":{"measure":"Change From Baseline in Modified Neuropathy Impairment Score Plus 7 (mNIS+7) at Week 66","timeFrame":"Baseline, Week 66","effectByArm":[{"arm":"Eplontersen","deltaMin":0.2964,"sd":2.4123},{"arm":"External Placebo","deltaMin":25.0557,"sd":2.3874}],"pValues":[{"comp":"OG000 vs OG001","p":"0.00000001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":45,"countries":["United States","Argentina","Australia","Brazil","Canada","Cyprus","France","Germany","Greece","Italy","New Zealand","Portugal","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["37768671","36525140","33638113"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":27,"n":144},"commonTop":["COVID-19","Urinary tract infection","Diarrhoea","Vitamin A deficiency","Nausea"]}}